Skip to main content

previous disabled Page of 50
and
  1. Article

    Open Access

    Atrial fibrillation fact sheet in Korea 2024 (part 1): epidemiology of atrial fibrillation in Korea

    This study aimed to analyze and present updated trends in atrial fibrillation (AF) epidemiology within the Korean population, providing a foundation for planning and implementing appropriate management and tr...

    So-Ryoung Lee, Daehoon Kim, Sung Ho Lee in International Journal of Arrhythmia (2024)

  2. No Access

    Article

    Aficamten reduces symptoms in obstructive hypertrophic cardiomyopathy

    Data from the SEQUOIA-HCM trial show that aficamten, a cardiac myosin inhibitor, increases exercise capacity and improves quality of life in patients with symptomatic obstructive hypertrophic cardiomyopathy.

    Gregory B. Lim in Nature Reviews Cardiology (2024)

  3. Article

    Open Access

    Comparing blood pressure measurements between sitting in chairs and sitting on the floor

    The current standard approach to measuring home blood pressure (BP) involves taking measurements while sitting in a chair. In cultures where floor sitting is common, including Korea, assessing BP while sitting...

    Byung Sik Kim, Young-Hyo Lim, Woohyeun Kim, Hyungdon Kook in Clinical Hypertension (2024)

  4. Article

    Open Access

    Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study

    Several studies have reported that pravastatin can mitigate the progression of kidney disease, but limited evidence exists regarding its effects on kidney function in Asian patients. This multicenter prospecti...

    Hae ** Kim, Kyu Yeon Hur, Yong-Ho Lee, ** Taek Kim, Yong-Kyu Lee in Advances in Therapy (2024)

  5. Article

    Open Access

    Incident heart failure and the subsequent risk of progression to end stage kidney disease in individuals with type 2 diabetes

    Diabetic kidney disease is an established risk factor for heart failure. However, the impact of incident heart failure on the subsequent risk of renal failure has not been systematically assessed in diabetic p...

    Sylvia Liu, Jian-Jun Liu, Keven Ang, Janus Lee, Clara Chan in Cardiovascular Diabetology (2024)

  6. No Access

    Article

    RNA interference lowers triglyceride levels

    Data from the phase IIb MUIR and ARCHES-2 trials show that RNA interference approaches that target either apolipoprotein C-III or ANGPTL3 significantly reduce plasma triglyceride levels in patients with mixed ...

    Gregory B. Lim in Nature Reviews Cardiology (2024)

  7. Article

    Open Access

    Sex-specific outcomes and left atrial remodeling following catheter ablation of persistent atrial fibrillation: results from the DECAAF II trial

    Catheter ablation is recognized as an effective treatment for atrial fibrillation (AF). Despite its effectiveness, significant sex-specific differences have been observed, which influence the outcomes of the p...

    Hadi Younes, Christian Sohns, Nazem Akoum in Journal of Interventional Cardiac Electrop… (2024)

  8. No Access

    Article

    A Novel Mental Health Curriculum Pilot for Pediatric Cardiology Fellows: Preparing the Subspecialist to Expand the Team

    Mental health (MH) is an important, yet understudied area of care for patients with congenital heart disease (CHD). Pediatric subspecialty fellows believe MH should be within their scope of practice, but few f...

    Amanda D. McCormick, Sonal T. Owens, Heang M. Lim, Carolyn Vitale in Pediatric Cardiology (2024)

  9. No Access

    Article

    No benefit of apoA-I infusion after myocardial infarction

    In the AEGIS-II trial, infusion of apolipoprotein A-I to increase cholesterol efflux capacity did not improve outcomes in patients with acute myocardial infarction.

    Gregory B. Lim in Nature Reviews Cardiology (2024)

  10. No Access

    Article

    Periodontal treatment reduces AF recurrence

    Treatment for periodontal disease might reduce the recurrence of atrial fibrillation (AF) in patients undergoing ablation, suggesting that periodontitis is a modifiable risk factor for AF.

    Gregory B. Lim in Nature Reviews Cardiology (2024)

  11. No Access

    Article

    Benefits of ninerafaxstat in non-obstructive hypertrophic cardiomyopathy

    According to data from the IMPROVE-HCM trial, ninerafaxstat is well tolerated by patients with symptomatic non-obstructive hypertrophic cardiomyopathy and improves exercise performance among those who are most...

    Gregory B. Lim in Nature Reviews Cardiology (2024)

  12. No Access

    Article

    No benefit of β-blockers after myocardial infarction with preserved ejection fraction

    In the REDUCE-AMI trial, the use of β-blockers in patients with acute myocardial infarction (MI) who have undergone early coronary angiography and have a preserved left ventricular ejection fraction did not re...

    Gregory B. Lim in Nature Reviews Cardiology (2024)

  13. Article

    Open Access

    Derivation of Stroke Volume from Pulmonary Artery Pressures

    Intermittent cardiac output (CO) studies using thermodilution are considered the gold standard. We have developed a stroke volume (SV) calculator from pulmonary pulse pressure (PP) to allow continuous monitori...

    Ivan H. W. Yim, Nigel E. Drury, Hoong Sern Lim in Cardiology and Therapy (2024)

  14. No Access

    Article

    Incidence and progression of atrial fibrillation in patients with and without heart failure using mineralocorticoid receptor antagonists: a meta-analysis

    Mineralocorticoid receptor antagonists (MRAs) have emerged as potential therapy to target the underlying arrhythmogenic substrate in atrial fibrillation (AF). Nevertheless, there have been inconsistent results...

    Thalys Sampaio Rodrigues, Levindo Jose Garcia Quarto in Clinical Research in Cardiology (2024)

  15. No Access

    Article

    Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases

    Thromboembolic diseases including arterial and venous thrombosis are common causes of morbidity and mortality globally. Thrombosis frequently recurs and can also complicate many inflammatory conditions through...

    Julie Wang, Prahlad Ho, Harshal Nandurkar in Journal of Thrombosis and Thrombolysis (2024)

  16. No Access

    Article

    Patent foramen ovale closure in ischemic stroke patients with and without thrombophilia: a systematic review and meta-analyses

    Ischemic stroke patients with thrombophilia and patient foramen ovale (PFO) may have an increased risk of recurrent stroke and transient ischemic attack (TIA), and may benefit from PFO closure. However, screen...

    Xue Yang Lim, Nicholas LX Gao, Wynne Yu Lee in Journal of Thrombosis and Thrombolysis (2024)

  17. Article

    Open Access

    Secondary cardiac lymphoma presenting with cardiac tamponade and cardiac mass: a case report

    Cardiac tamponade as the presenting manifestation of systemic lymphoma is relatively uncommon. Pericardium is the commonest site of involvement in secondary malignancies with systemic lymphoma involving the he...

    Wei Juan Lim, Neerusha Kaisbain, Rafidah Abu Bakar, Hafidz Abd Hadi in Cardio-Oncology (2024)

  18. No Access

    Article

    Metabolic product of excess niacin is linked to increased risk of cardiovascular events

    A metabolic product of excess niacin promotes vascular inflammation in preclinical models and is associated with increased rates of major adverse cardiovascular events in humans.

    Gregory B. Lim in Nature Reviews Cardiology (2024)

  19. Article

    Open Access

    Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study

    The TOujeo BEyond glucose control (TOBE) study evaluated clinical outcomes with insulin glargine 300 units/mL (Gla-300) in insulin-naïve Korean people with type 2 diabetes mellitus (T2DM) in a real-world setting.

    Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn in Advances in Therapy (2024)

  20. Article

    Open Access

    Therapeutic potential of conduction system pacing as a method for improving cardiac output during ventricular tachycardia

    Ventricular tachycardia (VT) reduces cardiac output through high heart rates, loss of atrioventricular synchrony, and loss of ventricular synchrony. We studied the contribution of each mechanism and explored t...

    Daniel Keene, Alejandra A. Miyazawa in Journal of Interventional Cardiac Electrop… (2024)

previous disabled Page of 50